• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于抗炎和/或 COX-2 抑制性贻贝类代谢产物的平衡 COX 抑制剂设计。

Design of balanced COX inhibitors based on anti-inflammatory and/or COX-2 inhibitory ascidian metabolites.

机构信息

College of Pharmacy, Pusan National University, Busan, 46241, Republic of Korea.

College of Pharmacy, Kyunghee University, Seoul, 02447, Republic of Korea.

出版信息

Eur J Med Chem. 2019 Oct 15;180:86-98. doi: 10.1016/j.ejmech.2019.07.016. Epub 2019 Jul 6.

DOI:10.1016/j.ejmech.2019.07.016
PMID:31301566
Abstract

The aim of this study was to design and synthesize COX-1/COX-2 balanced inhibitors incorporating the structural motifs of anti-inflammatory ascidian metabolites. We designed a series of substituted indole analogs that incorporate the key structures of the ascidian metabolites, herdmanines C and D. The synthesized analogs were tested for their inhibitory activity against COX-1 and COX-2, and compound 5m, which displayed balanced inhibition, was further evaluated for in vitro anti-inflammatory activity. Compound 5m suppressed the expression of pro-inflammatory factors, including iNOS, COX-2, TNF-α, and IL-6 in LPS-stimulated murine RAW264.7 macrophages. The reduction of PGE, NO, and ROS was also observed, together with the suppression of NF-κB, IKK, and IκBα phosphorylation. Our results characterized 5m as a COX-1/COX-2 balanced inhibitor that subsequently caused ROS inhibition and NF-κB suppression, and culminated in the suppression of iNOS, COX-2, TNF-α, and IL-6 expression.

摘要

本研究旨在设计和合成 COX-1/COX-2 平衡抑制剂,将抗炎海洋生物活性物质 herdmanines C 和 D 的结构母核纳入其中。我们设计了一系列取代的吲哚类似物,其中包含海洋生物活性物质 herdmanines C 和 D 的关键结构。合成的类似物被测试对 COX-1 和 COX-2 的抑制活性,化合物 5m 表现出平衡抑制作用,进一步评估其体外抗炎活性。化合物 5m 抑制 LPS 刺激的鼠 RAW264.7 巨噬细胞中促炎因子的表达,包括 iNOS、COX-2、TNF-α 和 IL-6。还观察到 PGE、NO 和 ROS 的减少,以及 NF-κB、IKK 和 IκBα 磷酸化的抑制。我们的研究结果表明 5m 是一种 COX-1/COX-2 平衡抑制剂,随后抑制 ROS 和 NF-κB,从而抑制 iNOS、COX-2、TNF-α 和 IL-6 的表达。

相似文献

1
Design of balanced COX inhibitors based on anti-inflammatory and/or COX-2 inhibitory ascidian metabolites.基于抗炎和/或 COX-2 抑制性贻贝类代谢产物的平衡 COX 抑制剂设计。
Eur J Med Chem. 2019 Oct 15;180:86-98. doi: 10.1016/j.ejmech.2019.07.016. Epub 2019 Jul 6.
2
Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole.含三唑的嘧啶酮衍生物的设计、合成、抗炎活性及分子对接研究
Bioorg Med Chem Lett. 2017 Sep 15;27(18):4409-4414. doi: 10.1016/j.bmcl.2017.08.014. Epub 2017 Aug 9.
3
Design of Balanced Cyclooxygenase Inhibitors Based on Natural Anti-inflammatory Ascidian Metabolites and Celecoxib.基于天然抗炎海鞘代谢产物和塞来昔布的平衡型环氧化酶抑制剂的设计
ChemMedChem. 2023 Dec 1;18(23):e202300468. doi: 10.1002/cmdc.202300468. Epub 2023 Oct 19.
4
Rationally designed hybrid molecules with appreciable COX-2 inhibitory and anti-nociceptive activities.具有明显 COX-2 抑制和抗伤害感受活性的合理设计的杂合分子。
Bioorg Med Chem Lett. 2014 Jan 1;24(1):77-82. doi: 10.1016/j.bmcl.2013.11.080. Epub 2013 Dec 4.
5
New methyl 5-(halomethyl)-1-aryl-1H-1,2,4-triazole-3-carboxylates as selective COX-2 inhibitors and anti-inflammatory agents: Design, synthesis, biological evaluation, and docking study.新型 N-甲基 5-(卤代甲基)-1-芳基-1H-1,2,4-三唑-3-羧酸酯作为选择性 COX-2 抑制剂和抗炎剂:设计、合成、生物评价和对接研究。
Bioorg Chem. 2020 Nov;104:104333. doi: 10.1016/j.bioorg.2020.104333. Epub 2020 Oct 2.
6
Dual COX-2 and 15-LOX inhibition study of novel 4-arylidine-2-mercapto-1-phenyl-1H-imidazolidin-5(4H)-ones: Design, synthesis, docking, and anti-inflammatory activity.新型4-亚芳基-2-巯基-1-苯基-1H-咪唑啉-5(4H)-酮的COX-2和15-LOX双重抑制研究:设计、合成、对接及抗炎活性
Arch Pharm (Weinheim). 2024 May;357(5):e2300615. doi: 10.1002/ardp.202300615. Epub 2024 Feb 5.
7
Novel trifluoromethyl ketone derivatives as oral cPLA/COX-2 dual inhibitors for resolution of inflammation in rheumatoid arthritis.新型三氟甲基酮衍生物作为口服 cPLA/COX-2 双重抑制剂,用于解决类风湿性关节炎中的炎症反应。
Bioorg Chem. 2024 Jul;148:107453. doi: 10.1016/j.bioorg.2024.107453. Epub 2024 May 14.
8
Biological and anti-inflammatory evaluation of two thiazole compounds in RAW cell line: potential cyclooxygenase-2 specific inhibitors.两种噻唑类化合物在 RAW 细胞系中的生物和抗炎评价:潜在的环氧化酶-2 特异性抑制剂。
Med Chem. 2012 May;8(3):401-8. doi: 10.2174/1573406411208030401.
9
Design & synthesis of novel oxazolone & triazinone derivatives and their biological evaluation as COX-2 inhibitors.新型恶唑酮和三嗪酮衍生物的设计与合成及其作为COX-2抑制剂的生物学评价
Bioorg Chem. 2017 Jun;72:308-314. doi: 10.1016/j.bioorg.2017.04.012. Epub 2017 Apr 24.
10
Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors.新型 1,2-二芳基-4-取代苄叉基-5(4H)-咪唑啉酮衍生物的设计、合成及作为细胞毒剂和 COX-2/LOX 抑制剂的生物评价。
Arch Pharm (Weinheim). 2018 Apr;351(3-4):e1700311. doi: 10.1002/ardp.201700311. Epub 2018 Feb 5.

引用本文的文献

1
Dual COX-2/TNF-α Inhibitors as Promising Anti-inflammatory and Cancer Chemopreventive Agents: A Review.双重COX-2/TNF-α抑制剂作为有前景的抗炎和癌症化学预防剂:综述
Iran J Pharm Res. 2024 Oct 29;23(1):e151312. doi: 10.5812/ijpr-151312. eCollection 2024 Jan-Dec.
2
Immunomodulatory Compounds from the Sea: From the Origins to a Modern Marine Pharmacopoeia.海洋免疫调节剂:从起源到现代海洋药物学。
Mar Drugs. 2024 Jun 28;22(7):304. doi: 10.3390/md22070304.
3
Synthesis, , evaluation of furanyl- and thiophenyl-3-phenyl-1-indole-2-carbohydrazide derivatives as tubulin inhibitors and anticancer agents.
呋喃基和噻吩基-3-苯基-1-吲哚-2-碳酰肼衍生物作为微管蛋白抑制剂和抗癌剂的合成、 及评价 。 (注:原英文文本中“evaluation”前多了个逗号,表述有误)
RSC Med Chem. 2024 May 28;15(7):2483-2495. doi: 10.1039/d4md00210e. eCollection 2024 Jul 17.
4
Current Status of Indole-Derived Marine Natural Products: Synthetic Approaches and Therapeutic Applications.吲哚衍生海洋天然产物的研究现状:合成方法与治疗应用。
Mar Drugs. 2024 Mar 6;22(3):126. doi: 10.3390/md22030126.
5
Non-steroidal Anti-inflammatory Drug (NSAID)-, Potassium Supplement-, Bisphosphonate-, and Doxycycline-Mediated Peptic Ulcer Effects: A Narrative Review.非甾体抗炎药(NSAID)、钾补充剂、双膦酸盐和强力霉素介导的消化性溃疡作用:一项叙述性综述。
Cureus. 2024 Jan 8;16(1):e51894. doi: 10.7759/cureus.51894. eCollection 2024 Jan.
6
A Computational Method for the Binding Mode Prediction of COX-1 and COX-2 Inhibitors: Analyzing the Union of Coxibs, Oxicams, Propionic and Acetic Acids.一种用于COX-1和COX-2抑制剂结合模式预测的计算方法:分析昔布类、昔康类、丙酸类和乙酸类药物的联合作用
Pharmaceuticals (Basel). 2023 Dec 4;16(12):1688. doi: 10.3390/ph16121688.
7
Green synthesis of highly functionalized heterocyclic bearing pyrazole moiety for cancer-targeted chemo/radioisotope therapy.用于癌症靶向化学/放射性同位素治疗的含吡唑部分的高官能化杂环的绿色合成。
BMC Chem. 2023 Oct 18;17(1):139. doi: 10.1186/s13065-023-01053-7.
8
Isolation and Identification of a Novel Anti-Dry Eye Peptide from Tilapia Skin Peptides Based on In Silico, In Vitro, and In Vivo Approaches.基于计算机模拟、体外和体内方法从罗非鱼皮肽中分离和鉴定一种新型抗干眼肽。
Int J Mol Sci. 2023 Aug 14;24(16):12772. doi: 10.3390/ijms241612772.
9
Design and Development of COX-II Inhibitors: Current Scenario and Future Perspective.COX-II 抑制剂的设计与开发:现状与未来展望
ACS Omega. 2023 May 9;8(20):17446-17498. doi: 10.1021/acsomega.3c00692. eCollection 2023 May 23.
10
Towards safer anti-inflammatory therapy: synthesis of new thymol-pyrazole hybrids as dual COX-2/5-LOX inhibitors.朝着更安全的抗炎治疗迈进:新型百里香酚-吡唑杂合体的合成作为双重 COX-2/5-LOX 抑制剂。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):294-308. doi: 10.1080/14756366.2022.2147164.